Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome

NCT00814515 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

482

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Dry Eye Syndrome

Interventions

DRUG: NOVA22007 (Ciclosporin 0.1%)
DRUG: NOVA22007

Sponsor

Santen SAS